By combining folinic acid therapy with targeted methylation support, the risks of serotonin depletion and exacerbated undermethylation symptoms can be minimized, allowing individuals with autism to benefit from brain folate restoration while maintaining neurotransmitter balance
GLP-1 receptor agonists and changes in eating behaviors and eating disorder risk: a rapid review
Glucagon-like peptide 1 receptor agonist, exendin-4, reduces alcohol-associated fatty liver disease
The FDA (US), TGA (Australia), MHRA (UK), and EMA (EU) have all issued warnings about melanotan products
This discovery can shift our perception of metabolic health, highlighting chronic low-grade inflammation as a central factor in metabolic dysfunction and a broader array of chronic diseases
Hormonal imbalance (with misuse) Excessive dosing or unsupervised use may disrupt natural endocrine function